ACTRN12616001256460已完成未知
Online Treatment of Food Cravings in Overweight and Obese Adults using Emotional Freedom Techniques
Bond University0 个研究点目标入组 120 人开始时间: 2016年9月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •18 years and over
- •Body Mass Index greater than 25 (overweight)
- •Access to internet, email
排除标准
- •Body Mass Index in healthy range, or underweight
研究者
相似试验
进行中（未招募）
1 期
Efficacy and Safety of Sotagliflozin versus Placebo in Subjects with Type 2 Diabetes Mellitus who have inadequate glycemic control while Taking Insulin Alone or with Other Oral Antidiabetic AgentsType 2 diabetes mellitusMedDRA version: 20.0Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2016-001804-43-BGSanofi-aventis Recherche & Développement571
进行中（未招募）
不适用
Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects with Non-malignant Chronic Pain Receiving Opioid TherapyEUCTR2013-002948-91-ATShionogi Inc.540
进行中（未招募）
1 期
GRAVITI - A Phase 3 Study to Evaluate the Efficacy and Safety of Guselkumab Subcutaneous Induction Therapy in Participants with Moderately to Severely Active Crohn's DiseaseModerately to Severely Active Crohn's DiseaseMedDRA version: 20.0Level: PTClassification code: 10011401Term: Crohn's disease Class: 100000004856CTIS2023-504737-41-00Janssen - Cilag International510
进行中（未招募）
1 期
Evaluation of Dupilumab in Children with Uncontrolled Asthma (Liberty Asthma Voyage)AsthmaEUCTR2016-001607-23-ITSanofi-Aventis Recherche & Développement838
进行中（未招募）
1 期
Pivotal study to assess the efficacy, safety and tolerability of dupilumab in patients with moderate-tosevere COPD with Type 2 inflammation (BOREAS)Chronic obstructive pulmonary diseaseMedDRA version: 21.1Level: PTClassification code 10009033Term: Chronic obstructive pulmonary diseaseSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2018-001953-28-ROSanofi-aventis Recherche & Développement2,054